Insider Trading Alert - VIVO, CCG And PDCE Traded By Insiders - TheStreet

Yesterday, Nov. 24, 2015, 106 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $189.51 to $48,391,506.50.

Highlighted Stocks Traded by Insiders:

Meridian Bioscience (VIVO) - FREE Research Report

McIlwraith John, who is Director at Meridian Bioscience, bought 1,000 shares at $20.19 on Nov. 24, 2015. Following this transaction, the Director owned 2,000 shares meaning that the stake was boosted by 100% with the 1,000-share transaction.

The shares most recently traded at $19.25, down $0.94, or 4.87% since the insider transaction. Historical insider transactions for Meridian Bioscience go as follows:

  • 4-Week # shares bought: 1,980
  • 4-Week # shares sold: 1,917
  • 12-Week # shares bought: 1,980
  • 12-Week # shares sold: 1,917
  • 24-Week # shares bought: 1,980
  • 24-Week # shares sold: 1,917

The average volume for Meridian Bioscience has been 224,200 shares per day over the past 30 days. Meridian Bioscience has a market cap of $798.4 million and is part of the health care sector and drugs industry. Shares are up 16.83% year-to-date as of the close of trading on Tuesday.

Meridian Bioscience, Inc., a life science company, develops, manufactures, and distributes diagnostic test kits primarily for certain gastrointestinal, viral, respiratory, and parasitic infectious diseases. The company operates through Diagnostics and Life Science segments. The stock currently has a dividend yield of 4.18%. The company has a P/E ratio of 22.8. Currently, there are 2 analysts who rate Meridian Bioscience a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VIVO - FREE

TheStreet Quant Ratings

rates Meridian Bioscience as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, solid stock price performance, expanding profit margins and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full

Meridian Bioscience Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Campus Crest Communities (CCG) - FREE Research Report

Mikulich Raymond C, who is Director at Campus Crest Communities, bought 28,913 shares at $6.62 on Nov. 24, 2015. Following this transaction, the Director owned 61,900 shares meaning that the stake was boosted by 87.65% with the 28,913-share transaction.

McWilliams Curtis B, who is Director at Campus Crest Communities, bought 10,000 shares at $6.62 on Nov. 24, 2015. Following this transaction, the Director owned 17,000 shares meaning that the stake was boosted by 142.86% with the 10,000-share transaction.

Halfacre Aaron Scott, who is Pres. & Chief Invest. Officer at Campus Crest Communities, bought 10,000 shares at $6.61 on Nov. 24, 2015. Following this transaction, the Pres. & Chief Invest. Officer owned 166,250 shares meaning that the stake was boosted by 6.4% with the 10,000-share transaction.

The shares most recently traded at $6.65, up $0.04, or 0.54% since the insider transaction. Historical insider transactions for Campus Crest Communities go as follows:

  • 4-Week # shares bought: 1,087
  • 12-Week # shares bought: 1,087
  • 24-Week # shares bought: 1,087
  • 24-Week # shares sold: 2,000

The average volume for Campus Crest Communities has been 796,700 shares per day over the past 30 days. Campus Crest Communities has a market cap of $427.4 million and is part of the financial sector and real estate industry. Shares are down 9.17% year-to-date as of the close of trading on Tuesday.

Campus Crest Communities, Inc., a real estate investment trust (REIT), engages in the ownership, development, building, and management of student housing properties under the Grove brand name in the United States. The stock currently has a dividend yield of 6.56%. Currently, there is 1 analyst who rates Campus Crest Communities a buy, 2 analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CCG - FREE

TheStreet Quant Ratings

rates Campus Crest Communities as a

sell

. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. Get the full

Campus Crest Communities Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

PDC Energy (PDCE) - FREE Research Report

Crisafio Anthony J, who is Director at PDC Energy, sold 1,000 shares at $54.79 on Nov. 24, 2015. Following this transaction, the Director owned 18,070 shares meaning that the stake was reduced by 5.24% with the 1,000-share transaction.

The shares most recently traded at $56.44, up $1.65, or 2.92% since the insider transaction. Historical insider transactions for PDC Energy go as follows:

  • 4-Week # shares sold: 61,193
  • 12-Week # shares sold: 61,193
  • 24-Week # shares sold: 61,843

The average volume for PDC Energy has been 1.0 million shares per day over the past 30 days. PDC Energy has a market cap of $2.2 billion and is part of the basic materials sector and energy industry. Shares are up 38.74% year-to-date as of the close of trading on Tuesday.

PDC Energy, Inc., an independent exploration and production company, acquires, explores for, develops, and produces crude oil, natural gas, and natural gas liquids in the United States. The company operates in two segments: Oil and Gas Exploration and Production, and Gas Marketing. The company has a P/E ratio of 119.2. Currently, there are 18 analysts who rate PDC Energy a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PDCE - FREE

TheStreet Quant Ratings

rates PDC Energy as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, disappointing return on equity and poor profit margins. Get the full

PDC Energy Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.